Table 1.
Jackson and Parker classification | |
Paragranuloma | |
Granuloma | |
Sarcoma | |
| |
Lukes and Butler classification | |
Lymphocytic and/or histiocytic, nodular | |
Lymphocytic and/or histiocytic, diffuse | |
Nodular sclerosis | |
Mixed cellularity | |
Diffuse fibrosis | |
Reticular | |
| |
Rye conference classification | |
Lymphocyte predominance | |
Nodular sclerosis | |
Mixed cellularity | |
Lymphocytic depletion | |
| |
Revised European-American lymphoma (REAL) classification | |
Nodular lymphocyte predominance nodular/diffuse | |
Classic HL | |
Nodular sclerosis | |
Mixed cellularity | |
Lymphocyte depletion | |
Lymphocyte rich classic HL diffuse (provisional entity) | |
| |
World Health Organisation scheme | |
Nodular lymphocyte predominant HL | |
Classic HL | |
Nodular sclerosis HL (grades 1 and 2) | |
Lymphocyte-rich classic HL* | |
Mixed cellularity HL | |
Lymphocyte-depleted HL | |
Unclassifiable classic HL |
*This includes a nodular (common) and a diffuse (rare) form in contrast to the REAL classification.